Health‐related quality of life · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease progression · participants with unresectable hepatocellular carcinoma
It is very uncertain whether E1B‐deleted (dl1520) adenovirus changes proportion of people with disease progression compared with percutaneous ethanol injection (very low certainty).
1 finding from 1 review
Adverse events considered non‐serious · participants with unresectable hepatocellular carcinoma
It is very uncertain whether E1B‐deleted (dl1520) adenovirus changes adverse events considered non‐serious (number of participants) compared with percutaneous ethanol injection (very low certainty).
1 finding from 1 review
All‐cause mortality · participants with unresectable hepatocellular carcinoma
It is very uncertain whether adenovirus‐thymidine kinase with ganciclovir (ADV‐TK/GCV) plus liver… changes all‐cause mortality compared with liver transplantation (very low certainty).
1 finding from 1 review
Proportion of people with ≥ 1 serious adverse events during treatment · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease progression · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tinnitus symptom severity · adults with subjective idiopathic tinnitus
1 finding from 1 review
Significant adverse effect: increase in self‐reported tinnitus loudness · adults with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depressive symptoms · adults with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · adults with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects associated with wearing the device (such as pain, discomfort, tenderness or skin irritation, or ear infections) · adults with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abstinence · people who smoke
Active NRT probably leads to higher abstinence at end of treatment compared with placebo ‐ rs1051730 ‐ non‐Hispanic white (moderate certainty).
1 finding from 1 review
6‐Month abstinence ‐ homozygous major · people who smoke
Active NRT leads to higher abstinence at 6 months ‐ homozygous major compared with placebo ‐ rs16969968 ‐ non‐Hispanic black or African American (high certainty).
1 finding from 1 review
6‐Month abstinence ‐ heterozygous or homozygous minor · people who smoke
Active NRT showed no clear difference in abstinence at 6 months ‐ heterozygous or homozygous minor compared with placebo ‐ rs16969968 ‐ non‐Hispanic black or African American (low certainty).
1 finding from 1 review
Abstinence · people who smoke
Active NRT showed no clear difference in abstinence at end of treatment compared with placebo ‐ rs16969968 ‐ non‐Hispanic black or African American (moderate certainty).
2 findings from 1 review
Abstinence at end of treatment ‐ homozygous major · people who smoke
Active NRT leads to higher abstinence at end of treatment ‐ homozygous major compared with placebo ‐ rs16969968 ‐ non‐Hispanic black or African American (high certainty).
1 finding from 1 review
Abstinence at end of treatment ‐ heterozygous or homozygous minor · people who smoke
Active NRT probably leads to lower abstinence at end of treatment ‐ heterozygous or homozygous minor compared with placebo ‐ rs16969968 ‐ non‐Hispanic black or African American (moderate certainty).
1 finding from 1 review
End of treatment · people who smoke
Active NRT probably leads to higher end of treatment compared with placebo ‐ rs 588765 ‐ non‐Hispanic white (moderate certainty).
1 finding from 1 review
End of treatment ‐ homozygous major · people who smoke
Active NRT showed no clear difference in end of treatment ‐ homozygous major compared with placebo ‐ rs 588765 ‐ non‐Hispanic white (low certainty).
1 finding from 1 review